Bausch Health Companies (BHC) PT Lowered to $27 at Barclays
Tweet
Share
E-mailGet Alerts BHC Hot Sheet
Price: $6.51 +2.68%
Rating Summary:
11 Buy, 15 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Rating Summary:
11 Buy, 15 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Join SI Premium – FREE
Barclays analyst Balaji Prasad lowered the price target on Bausch Health Companies (NYSE: BHC) to $27.00 (from $29.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
- KBC Group (KBC:BB) (KBCSY) PT Raised to EUR117 at Barclays
- Stroeer SE & Co KGaA (SAX:GR) PT Raised to EUR52 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
